Masthead

Doctors, Patients Discuss New Hope for Relapsed Hodgkin's Lymphoma

| Comments (0)

Hodgkin's lymphoma is one of the more curable cancers. About 75% of patients are cured by initial therapy.

However, for those failed by chemotherapy, there is no standard therapy. New drugs moving through clinical trials at MD Anderson appear to provide an answer for resistant or relapsed Hodgkin's lymphoma.

Two MD Anderson patients and two oncologists from the Department of Lymphoma/Myeloma talk about the latest developments at Patient Power 


Breakthroughs in Lymphoma from Patient Power® on Vimeo.

twitter_icon_15.jpgFollow Dr. Younes on Twitter

Leave a comment

Search

Connect on social media

Sign In

Archives